Independent Laboratory Billing of Automated Multi-Channel Chemistry (AMCC) Organ Disease Panel Laboratory Tests for Beneficiaries who are not Receiving Dialysis for Treatment of End Stage Renal Disease (ESRD)
This article is based on Change Request (CR) 7497 which updates requirements regarding Independent Laboratory (IL) billing of Automated Multi-Channel Chemistry (AMCC) organ disease panel laboratory tests for beneficiaries who are not receiving dialysis for treatment of End Stage Renal Disease (ESRD). Effective for services on or after January 1, 2012, CR7497 eliminates the requirement for ILs to bill separately for each individual AMCC laboratory test included in organ disease panel codes for ESRD eligible beneficiaries. Organ disease panels will be
paid under the Clinical Laboratory Fee Schedule and will not be subject to the 50/50 rule payment calculation when billed by ILs.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: August 02, 2011
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.